Intralink Insights

China’s biotech industry is on the rise. Five of the 10 largest biotech initial public offerings worldwide in the first half of 2019 were from Chinese companies, according to the Financial Times.

So, Jack Ma is retiring. The man who epitomizes the modern Chinese enterprise is stepping away from the technology empire he created. Let the eulogizing and speculation begin! 

A staggering 10% of China’s surface water is severely contaminated and defined as an ‘Inferior Grade V’ waterbody, according to 2016 government data.

East Asia represents immense opportunities for tech scale-ups targeting the automotive sector, but at the same time comes with considerable complexities.

Micah Hostetter from our Energy & Environment Group has just had an article published in Open Access Government on China’s acute pollution problems and its environmental sector, which is growing at a lightning pace to address them.

So, here we are again! Last year ZTE; this year Huawei. Exactly how much trouble is the company in? What are its – and the Chinese government’s – options from here? And could there be big opportunities for European and Asian tech firms to step in to fill the void of banned US technologies?